Where we are going, what we are discovering, and how we are helping our clients find the best road ahead.
According to recent data from Lazard, activist investors spent $62 billion advocating for corporate change in 2017. READ MORE
The media’s focus on drug costs also has increased attention on industry-advocacy relationships. READ MORE